Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Netilmicin 3mg/ml / Dexamethasone 1mg/ml eye drops
1104010X0AAACAC
|
Netilmicin/Dexamethasone | Netilmicin/Dexamethasone | Eye | No data available |
|
Netilmicin 3mg/ml eye drops
1103010AMAAABAB
|
Netilmicin | Netilmicin (Eye) | Eye | No data available |
|
Netilmicin 50mg/1ml solution for injection ampoules
0501040R0AAABAB
|
Netilmicin sulfate | Netilmicin sulfate | Infections | No data available |
|
Nettacin 3mg/ml eye drops
1103010AMBBABAB
|
Nettacin | Netilmicin (Eye) | Eye | No data available |
|
Nettacin 3mg/ml eye drops 0.3ml unit dose
1103010AMBBAAAA
|
Nettacin | Netilmicin (Eye) | Eye | No data available |
|
Netupitant 300mg / Palonosetron hydrochloride 500microg caps
0406000AGAAAAAA
|
Netupitant/palonosteron hydrochloride | Netupitant/palonosetron hydrochloride | Central Nervous System | No data available |
|
Neulactil 10mg tablets
0402010P0BBABAE
|
Neulactil | Pericyazine | Central Nervous System | No data available |
|
Neulactil 2.5mg tablets
0402010P0BBAAAD
|
Neulactil | Pericyazine | Central Nervous System | No data available |
|
Neulactil Forte syrup
0402010P0BBADAC
|
Neulactil | Pericyazine | Central Nervous System | No data available |
|
Neulasta 6mg/0.6ml inj pfs with Onpro kit
0901060P0BBACAA
|
Neulasta | Pegfilgrastim | Nutrition and Blood | No data available |
|
Neulasta SureClick 6mg/0.6ml inj pf dispos dev
0901060P0BBABAB
|
Neulasta | Pegfilgrastim | Nutrition and Blood | No data available |
|
Neupedix 500micrograms/1ml concentrate for inf ampoules
0701011D0BCAAAB
|
Neupedix | Alprostadil | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Neupogen 30million units/1ml solution for injection vials
0901060I0BBAAAA
|
Neupogen | Filgrastim | Nutrition and Blood | No data available |
|
Neupogen 48million units/1.6ml solution for injection vials
0901060I0BBABAB
|
Neupogen | Filgrastim | Nutrition and Blood | No data available |
|
Neupogen Singleject 48million units/0.5ml inj pfs
0901060I0BBAFAM
|
Neupogen | Filgrastim | Nutrition and Blood | No data available |
|
Neupro transdermal patches treatment initiation pack
0409010Z0BBAEAE
|
Neupro | Rotigotine | Central Nervous System | No data available |
|
Neuro3 tablets
090602800BBJSDA
|
Proprietary compound preparation BNF 0906028 | Other vitamin B preparations | Nutrition and Blood | No data available |
|
NeuroBloc 10,000units/2ml solution for injection vials
0409030A0BBACAC
|
Neurobloc | Botulinum toxin type B | Central Nervous System | No data available |
|
NeuroBloc 2,500units/0.5ml solution for injection vials
0409030A0BBAAAA
|
Neurobloc | Botulinum toxin type B | Central Nervous System | No data available |
|
NeuroBloc 5,000units/1ml solution for injection vials
0409030A0BBABAB
|
Neurobloc | Botulinum toxin type B | Central Nervous System | No data available |
|
Neurontin 250mg/5ml oral solution
0408010G0BBAFAQ
|
Neurontin | Gabapentin | Central Nervous System | No data available |
|
Neurontin titration pack
0408010G0BBAGAX
|
Neurontin | Gabapentin | Central Nervous System | No data available |
|
Neutratop 0.75% gel
1310012K0BHAAAR
|
Neutratop | Metronidazole | Skin | No data available |
|
Neutrogena Norwegian Formula Moisturisation foot cream
190205500BBRVA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Nevirapine 100mg modified-release tablets
0503010B0AAADAD
|
Nevirapine | Nevirapine | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.